485 related articles for article (PubMed ID: 17497612)
1. Weighted nonparametric maximum likelihood estimate of a mixing distribution in nonrandomized clinical trials.
Liu C; Xie J; Zhang Y
Stat Med; 2007 Dec; 26(29):5303-19. PubMed ID: 17497612
[TBL] [Abstract][Full Text] [Related]
2. Nonparametric empirical Bayes method for comparison of treatment effects with application to stress urinary incontinence data.
Liu C; Shen W; Xie J
Pharm Stat; 2008; 7(1):42-52. PubMed ID: 17311241
[TBL] [Abstract][Full Text] [Related]
3. Nonparametric estimation of ROC curves in the absence of a gold standard.
Zhou XH; Castelluccio P; Zhou C
Biometrics; 2005 Jun; 61(2):600-9. PubMed ID: 16011710
[TBL] [Abstract][Full Text] [Related]
4. Assessment of the Gould-Shih procedure for sample size re-estimation.
Waksman JA
Pharm Stat; 2007; 6(1):53-65. PubMed ID: 17133631
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of underlying risk as a source of heterogeneity in meta-analyses: a simulation study of Bayesian and frequentist implementations of three models.
Dohoo I; Stryhn H; Sanchez J
Prev Vet Med; 2007 Sep; 81(1-3):38-55. PubMed ID: 17477995
[TBL] [Abstract][Full Text] [Related]
6. Investigating trial and treatment heterogeneity in an individual patient data meta-analysis of survival data by means of the penalized maximum likelihood approach.
Rondeau V; Michiels S; Liquet B; Pignon JP
Stat Med; 2008 May; 27(11):1894-910. PubMed ID: 18069745
[TBL] [Abstract][Full Text] [Related]
7. Pseudolikelihood estimation of the Rasch model.
Smit A; Kelderman H
J Outcome Meas; 2000; 4(1):513-23. PubMed ID: 11272599
[TBL] [Abstract][Full Text] [Related]
8. A nonparametric smoothing method for assessing GEE models with longitudinal binary data.
Lin KC; Chen YJ; Shyr Y
Stat Med; 2008 Sep; 27(22):4428-39. PubMed ID: 18613210
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of the nonparametric estimation method in NONMEM VI.
Savic RM; Kjellsson MC; Karlsson MO
Eur J Pharm Sci; 2009 Apr; 37(1):27-35. PubMed ID: 19159684
[TBL] [Abstract][Full Text] [Related]
10. Estimating treatment efficacy over time: a logistic regression model for binary longitudinal outcomes.
Choi L; Dominici F; Zeger SL; Ouyang P
Stat Med; 2005 Sep; 24(18):2789-805. PubMed ID: 16134133
[TBL] [Abstract][Full Text] [Related]
11. A permutation test for inference in logistic regression with small- and moderate-sized data sets.
Potter DM
Stat Med; 2005 Mar; 24(5):693-708. PubMed ID: 15515134
[TBL] [Abstract][Full Text] [Related]
12. Non-parametric estimation and model checking procedures for marginal gap time distributions for recurrent events.
Kvist K; Gerster M; Andersen PK; Kessing LV
Stat Med; 2007 Dec; 26(30):5394-410. PubMed ID: 17994608
[TBL] [Abstract][Full Text] [Related]
13. The bayesian bias correction method of the first-order approximation of nonlinear mixed-effects models for population pharmacokinetics.
Funatogawa T; Funatogawa I
J Biopharm Stat; 2007; 17(3):381-92. PubMed ID: 17479388
[TBL] [Abstract][Full Text] [Related]
14. A comparison of statistical methods for clustered data analysis with Gaussian error.
Feng Z; McLerran D; Grizzle J
Stat Med; 1996 Aug; 15(16):1793-806. PubMed ID: 8870161
[TBL] [Abstract][Full Text] [Related]
15. Evaluating statistics in clinical trials: making the unintelligible intelligible.
Gilmore SJ
Australas J Dermatol; 2008 Nov; 49(4):177-84; quiz 185-6. PubMed ID: 18855776
[TBL] [Abstract][Full Text] [Related]
16. Slope estimation in the presence of informative right censoring: modeling the number of observations as a geometric random variable.
Mori M; Woolson RF; Woodworth GG
Biometrics; 1994 Mar; 50(1):39-50. PubMed ID: 8086614
[TBL] [Abstract][Full Text] [Related]
17. Continuous toxicity monitoring in phase II trials in oncology.
Ivanova A; Qaqish BF; Schell MJ
Biometrics; 2005 Jun; 61(2):540-5. PubMed ID: 16011702
[TBL] [Abstract][Full Text] [Related]
18. Maximum likelihood estimation of the attributable fraction from logistic models.
Greenland S; Drescher K
Biometrics; 1993 Sep; 49(3):865-72. PubMed ID: 8241375
[TBL] [Abstract][Full Text] [Related]
19. Maximum likelihood estimation of the kappa coefficient from bivariate logistic regression.
Shoukri MM; Mian IU
Stat Med; 1996 Jul; 15(13):1409-19. PubMed ID: 8841651
[TBL] [Abstract][Full Text] [Related]
20. The population risk as an explanatory variable in research synthesis of clinical trials.
McIntosh MW
Stat Med; 1996 Aug; 15(16):1713-28. PubMed ID: 8870154
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
